GleamWall
中文EN

LUCD Lucid Diagnostics Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1799011 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY23.6%
TTM net income YoY8.9%
TTM EPS YoY—
Revenue 3-yr CAGR53.6%
Net income 3-yr CAGR—

Margins

Gross margin-16.5%
Operating margin-941.7%
Net margin-892.8%
FCF margin-953.3%
EBITDA margin-925.5%

Returns

ROE-305.6%
ROA-119.8%
ROIC (approx.)—
Asset turnover0.13x

Leverage & solvency

Liabilities / assets78.7%
Debt / equity0.00x
Current ratio1.20x
Interest coverage-3,011.88x

Cash quality & payout

Operating cash flow / net income1.06x
Accruals ratio7.4%
Payout ratio—
Capex / revenue5.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$4.71M$4.35M
Cost of revenue$6.67M$7.10M
Gross profit-$1.96M-$2.75M
R&D expense$5.68M$5.99M
SG&A expense$23.87M$20.16M
Operating income-$49.64M-$46.05M
Interest expense$22,000$26,000
Pretax income-$58.01M-$45.53M
Income tax$0$0
Net income-$58.01M-$45.53M
EBITDA-$48.77M-$44.88M
EPS (basic)-0.69-1.05
EPS (diluted)—-1.05
Weighted avg. shares (diluted)—50.52M
Balance sheet
Cash & equivalents$34.70M$22.36M
Receivables$643,000$45,000
Inventory$353,000$341,000
Current assets$37.47M$25.15M
PP&E, net$809,000$1.06M
Intangibles$315,000$736,000
Total assets$40.45M$30.71M
Current liabilities$28.58M$23.52M
Total liabilities$29.51M$25.32M
Shareholders' equity$10.94M$5.39M
Shares outstanding131.10M63.07M
Cash flow statement
Operating cash flow-$46.48M-$44.14M
Capital expenditure$197,000$296,000
Free cash flow-$46.68M-$44.44M
Investing cash flow-$197,000-$646,000
Financing cash flow$59.03M$48.25M
Depreciation & amortization$872,000$1.17M
Stock-based compensation$4.49M$4.53M

Free plan shows the latest 2 periods; Pro shows all 6 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.